Digitek Digoxin Recall Information
July 30, 2008 by Herman Dorthchild
Filed under Digitek, Drug Recalls
Digitek (digoxin) tablets were recalled on April 25, 2008 by the FDA due to a manufacturers defect which allowed tablets to be produced with twice the approved amount of the active ingredient (digoxin). Digoxin is a medication given to those suffering from heart failure or heart arrythmias, and allows the heart to beat at a stronger, more normal, rate.
Digitek (digoxin) tablets are manufactured b Actavis Totowa and distributed by Mylan Pharmaceuticals. Digitek (digoxin) tablets are also sold under the labels UDL or Bertek. Recalled Digitek (digoxin) tablets appear larger and thicker in size due to the double dose of digoxin found in them.
The double dose of digoxin found in Digitek tablets may result in digitalis toxicity. Digitalis toxicity occurs when digoxin accumulates in high levels in the body and may result in death.
If you have lost the life of a loved one due to recalled Digitek (digoxin) tablets or suffered serious side effects yourself, contact a McEwen Law Firm attorney today. We offer free, no obligation, consultations and work on a contingency so you won’t need to pay anything unless we win your case.
Our attorneys are dedicated to providing you with the best legal support possible after your Digitek injury, and are determined to help you win your Digitek Lawsuit case. To reach an Digitek Recall Lawyer today call (800) 732-3070 or fill out our online contact form.